Whalegun
Home

Biomarin Pharmaceutical BMRN spent $390K on lobbying in Q4 2025 · Budget, Health Issues and 3 more issues

Trade details

Type
Lobbying report
Amount
$390,000
Quarter
Q4 2025
Stock
Biomarin Pharmaceutical BMRN
Client
Biomarin Pharmaceutical
Reported
26/01/20

Up 44.4% from last quarter

What else happened in Biomarin Pharmaceutical around then

Filed or reported within 30 days of the trade day · 25/12/01~01/30

Biomarin Pharmaceutical's other lobbying reports